arrow
S

Simona Piemontese

IRCCS Ospedale San Raffaele
H指数:19
被引数:1,673

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT

成人AML完全缓解伴可测量微小残留病患者间基因半相合、同胞全相合及无关供者allo-HCT的比较:EBMT全球委员会和ALWP的研究

2026-09-190
OAAI
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo)

异基因移植后急性髓系白血病复发的预防策略:GITMO(意大利骨髓移植组)全国调查

2026-08-050
PRE
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee

当代造血细胞移植中的HLA配型:EBMT实践协调与指南委员会的建议

2026-06-020
OAAI
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party

供者选择对不良风险AML接受造血细胞移植的影响:EBMT急性白血病工作组的研究

2025-11-290
PRE
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT

供者选择在PTCy半相合移植治疗急性淋巴细胞白血病中的应用:一项来自EBMT ALWP的研究

2025-11-250
PRE
Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study

基于马利兰与奥莫福安的预处理方案对异基因造血细胞移植后肝窦阻塞综合征/静脉闭塞病发生率的影响:一项双中心真实世界研究

2025-11-180
PRE
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study

移植物抗宿主病流行病学、预防和管理趋势:意大利骨髓移植、造血干细胞和细胞治疗小组(GITMO)GVHD24研究

2025-11-010
PRE
Beyond conventional adoptive T cell therapy

超越常规的过继性T细胞疗法

2025-08-210
OAAI
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients

验证Manhattan风险评分在Rapamycin和PTCy为基础的预防方案中预测aGvHD严重程度的价值:一项针对459例连续HCT患者的研究

2025-07-210
PRE
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

老年匹配同胞供者与年轻半相合供者用于老年急性髓系白血病患者

2025-07-180
OAAI
CC486 as a Safe and Effective Bridge to Transplant in MDS-del5q with Transfusion-Dependent Anemia Following Lenalidomide Relapse: A Case Report

CC486作为一种安全有效的移植桥梁,用于lenalidomide复发后的MDS-del5q伴输血依赖性贫血:一份病例报告

2025-07-090
PRE
Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Haploidentical Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

异基因移植中,复发/难治性急性髓系白血病患者采用环磷酰胺与抗胸腺细胞球蛋白的比较研究:欧洲血液和骨髓移植组急性白血病工作组的研究

BLOOD
IF23.1
2024-11-050
PRE
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
2024-09-201
OAAI
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide
LEUKEMIA
IF13.4
2024-07-240
PRE
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT
2024-05-174
OAAI